Muscle News and Research

RSS

Isis Pharmaceuticals begins ISIS-DMPK Rx clinical study in DM1 patients

Isis Pharmaceuticals, Inc. announced today that it has initiated a study for ISIS-DMPK Rx in patients with Myotonic Dystrophy Type 1 (DM1). DM1 is a rare genetic neuromuscular disease caused by the production of toxic dystrophia myotonica-protein kinase (DMPK) RNA in cells. ISIS-DMPKRx is specifically designed to reduce toxic DMPK RNA.

16 Dec 2014

Intronix Technologies, Western University collaborate to develop rehabilitation devices

Intronix Technologies will be collaborating with Western University's Department of Electrical and Computer Engineering to develop technology to be incorporated into rehabilitation devices.

16 Dec 2014

Joslin study could lead to improved anti-aging drugs

In a study published today by Nature, researchers at Joslin Diabetes Center used a microscopic worm (C. elegans) to identify a new path that could lead to drugs to slow aging and the chronic diseases that often accompany it--and might even lead to better cosmetics.

16 Dec 2014

Top ten priorities for research into management of Parkinson's

Patients with Parkinson's, medics and carers have identified the top ten priorities for research into the management of the condition in a study by the University of East Anglia and Parkinson's UK.

16 Dec 2014

UT Southwestern researchers identify cell signaling mechanism that plays vital role in brain cancer

UT Southwestern Medical Center neurology researchers have identified an important cell signaling mechanism that plays an important role in brain cancer and may provide a new therapeutic target.

16 Dec 2014

Roche announces launch of cobas Liat System for on-demand testing in different settings

Roche today announced the launch of the cobas Liat System—a fast, compact , easy to use, molecular diagnostic platform, designed for on-demand testing in physician clinics, pharmacies and hospital lab settings.

16 Dec 2014

Olympus receives FDA clearance for Narrow Band Imaging

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today FDA 510(k) clearance of Narrow Band Imaging (NBI) as enabling effective targeting of biopsies not seen under white light and improved visualization of tumor boundaries in Non-Muscle-Invasive Bladder Cancer (NMIBC) patients.

From Evident Corporation - Life Sciences 15 Dec 2014

Dr. Shirin Towfigh reveals possible symptoms that may help identify sports hernias

When playing sports that involve rapid bursts, twists, and movements, a variety of groin injuries, including hernias, can occur. No matter how strong or flexible someone is, their lower abdominal wall can still weaken because of constant or particularly straining rapid movement.

15 Dec 2014

Study: Coordinated emergency response could help improve patient survival from heart attack

A faster, coordinated emergency response in collaboration with hospital cardiac catheterization laboratories in each U.S. region, including New York City, is associated with improving patient survival from a heart attack caused by a sudden, completely blocked artery called an ST-elevated myocardial infarction (STEMI), according to a study presented at the American Heart Association Scientific Sessions 2014.

14 Dec 2014

ALS Association announces research funds to further understand genetic cause of ALS

The ALS Association is pleased to announce the award of $326,662 in research funds to expand ongoing natural history studies in order to further understand the most common genetic cause of ALS, in preparation for clinical trials in those whose disease is affected by this gene.

14 Dec 2014

FDA approves Fluzone Intradermal Quadrivalent vaccine to prevent four strains of influenza virus

Sanofi Pasteur, the vaccines division of Sanofi, today announced that the U.S. Food and Drug Administration has approved the supplemental biologics license application (sBLA) for Fluzone Intradermal Quadrivalent vaccine.

13 Dec 2014

Riding roller coasters can trigger stroke in children

Riding a couple roller coasters at an amusement park appears to have triggered an unusual stroke in a 4-year-old boy, according to a report in the journal Pediatric Neurology.

11 Dec 2014

STSI researchers launch study to examine root cause of sudden unexpected death

Researchers at the Scripps Translational Science Institute have launched a clinical trial aimed at cracking one of the toughest mysteries in forensic science -- sudden unexplained death.

11 Dec 2014

Potential new active substances for treating dengue virus

Researchers from Johannes Gutenberg University Mainz and the Julius Maximilian University of Würzburg are proposing potential new active substances for treating the dengue virus. Just like Ebola, dengue fever is also caused by a virus for which there is currently no cure and no vaccine and can be fatal.

11 Dec 2014

Study: Long-term endurance training alters epigenetic pattern in the human skeletal muscle

A new study from Karolinska Institutet in Sweden shows that long-term endurance training in a stable way alters the epigenetic pattern in the human skeletal muscle. The research team behind the study, which is being published in the journal Epigenetics, also found strong links between these altered epigenetic patterns and the activity in genes controlling improved metabolism and inflammation.

10 Dec 2014

New study investigates ways to help people with MS respond to sudden balance challenge

Many people with multiple sclerosis (MS) have trouble with balance and a fear of falling, which can have severe negative effects on their quality of life by keeping them away from social events, regular exercise and community activities. And, if they do get out, the fatigue and anxiety of walking can be very taxing.

10 Dec 2014

Loyola University Medical Center opens center to provide treatments for diseased heart valves

Loyola University Medical Center has opened a multidisciplinary Valve Center that offers patients a full range of treatments for diseased heart valves.

10 Dec 2014

Can-Fite to commence pre-clinical development program of CF602 drug for sexual dysfunction

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported that it will initiate a pre-clinical development program of its next generation drug CF602 for the indication of sexual dysfunction. Upon successful completion, the company intends to file an IND with the FDA to allow human Phase I studies.

9 Dec 2014

Combination therapy benefits patients with acute myeloid leukemia

Patients who relapse in their battle with acute myeloid leukemia (AML) may benefit from a phase three study of therapies that combine an existing agent, cytarabine, with a newer compound, vosaroxin.

8 Dec 2014

New trial shows efficacy of PrimiCell product on muscle repair

BioAdaptives, Inc. announced results of the recently completed in vivo trial showing the efficacy of its PrimiCell product on muscle repair.

8 Dec 2014

Muscle News and Research

Isis Pharmaceuticals begins ISIS-DMPK Rx clinical study in DM1 patients

Intronix Technologies, Western University collaborate to develop rehabilitation devices

Joslin study could lead to improved anti-aging drugs

Top ten priorities for research into management of Parkinson's

UT Southwestern researchers identify cell signaling mechanism that plays vital role in brain cancer

Roche announces launch of cobas Liat System for on-demand testing in different settings

Olympus receives FDA clearance for Narrow Band Imaging

Dr. Shirin Towfigh reveals possible symptoms that may help identify sports hernias

Study: Coordinated emergency response could help improve patient survival from heart attack

ALS Association announces research funds to further understand genetic cause of ALS

FDA approves Fluzone Intradermal Quadrivalent vaccine to prevent four strains of influenza virus

Riding roller coasters can trigger stroke in children

STSI researchers launch study to examine root cause of sudden unexpected death

Potential new active substances for treating dengue virus

Study: Long-term endurance training alters epigenetic pattern in the human skeletal muscle

New study investigates ways to help people with MS respond to sudden balance challenge

Loyola University Medical Center opens center to provide treatments for diseased heart valves

Can-Fite to commence pre-clinical development program of CF602 drug for sexual dysfunction

Combination therapy benefits patients with acute myeloid leukemia

New trial shows efficacy of PrimiCell product on muscle repair

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News